Browse > Article

Clinical Manifestation and Treatment Results of the Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Arising in the Head and Neck Region  

Rah, Yoon-Chan (Department of Otorhinolaryngology, Seoul National University College of Medicine)
Han, Kyu-Hee (Department of Otorhinolaryngology, Seoul National University College of Medicine)
An, Soo-Youn (Department of Otorhinolaryngology, Seoul National University College of Medicine)
Kwon, Tack-Kyun (Department of Otorhinolaryngology, Seoul National University College of Medicine)
Sung, Myung-Whun (Department of Otorhinolaryngology, Seoul National University College of Medicine)
Kim, Kwang-Hyun (Department of Otorhinolaryngology, Seoul National University College of Medicine)
Hah, J.-Hun (Department of Otorhinolaryngology, Seoul National University College of Medicine)
Publication Information
Korean Journal of Head & Neck Oncology / v.25, no.2, 2009 , pp. 128-131 More about this Journal
Abstract
Objectives : Mucosa-associated lymphoid tissue(MALT) lymphoma of the head and neck region is relatively rare, but it has variable clinical and biological characteristics. Although there were few studies on this topic, there is still controversy regarding the best treatment. The authors retrospectively investigated the clinical courses and treatment results in 10 patients presenting with MALT-lymphoma in head and neck region except ocular adnexa. Material and Methods : Ten patients with a histologically verified diagnosis of the extranodal marginal zone B cell lymphoma arising in thyroid glands(3), larynx(3), oral cavity(2), oropharynx(1), salivary glands(1) were analyzed. Results : Four patients were allocated to stage IE and another six patients to stage IIE according to the Ann Arbor staging system. Treatment consisted of local therapy(surgical resection and/or radiotherapy) in four patients and systemic chemotherapy with/without local therapy in six patients. Complete remission and partial remission were achieved in seven patients(70%) and two patients(20%), respectively. No recurrence or mortality was observed with a mean follow-up of 40.5 months. Conclusion : Patients with MALT-lymphomas of the head and neck region were potentially treated by local modality in localized disease state. However systemic chemotherapy was also effective even in localized disease state and was well tolerated by patients. And strict staging and close long-term monitoring were recommended considering its indolent progression.
Keywords
MALT lymphoma; Extranodal marginal zone B-cell lymphoma; Head and neck neoplasm;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Jacobs C, Weiss L, Hoppe RT. The management of extranodal head and neck lymphomas. Arch Otolaryngol Head Neck Surg. 1986;112:654-658   DOI   PUBMED   ScienceOn
2 Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A, et al. Eradication of Helicobacter pylori infection in primary lowgrade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med. 1995;122:767-769   DOI   PUBMED   ScienceOn
3 Ferreri AJ, Ponzoni M, Guidoboni M, Resti AG, Politi LS, Cortelazzo S, et al. Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: A multicenter prospective trial. J Natl Cancer Inst. 2006;98:1375-1382   DOI   ScienceOn
4 Wenzel C, Fiebiger W, Dieckmann K, Formanek M, Chott A, Raderer M. Extranodal marginal zone B-cell lymphoma of mucosaassociated lymphoid tissue of the head and neck area: High rate of disease recurrence following local therapy. Cancer. 2003;97:2236-2241   DOI   ScienceOn
5 Wozniak R, Beckwith L, Ratech H, Surks MI. Maltoma of the thyroid in a man with Hashimoto's thyroiditis. J Clin Endocrinol Metab. 1999;84:1206-1209   DOI   ScienceOn
6 Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, Dumontet C, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoa behavior: Analysis of 108 patients. J Clin Oncol. 1997;15:1624-1630   DOI   PUBMED
7 Suh CW, Huh JR, Roh JL. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid dissue arising in the extracranial head and neck region: A high rate of dissemination and disease recurrence. Oral Oncology. 2008;44:949-955   DOI   ScienceOn
8 Isaacson PG. Mucosa-associated lymphoid tissue lymphoma. Semin Hematol. 1999;36:139-147   PUBMED
9 Zinzani PL, Magagnoli M, Galieni P, Martelli M, Poletti V, Zaja F, et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: Analysis of 75 patients. J Clin Oncol. 1999;17:1254-1258   DOI   PUBMED
10 Raderer M, Vorbeck F, Formanek M, Osterreicher C, Valencak J, Penz M, et al. Importance of extenive staging in patients with mucosa-associated lymphoid tissue(MALT)-type lymphoma. Br J Cancer. 2000;83:454-457   DOI   ScienceOn
11 Bhattacharyya N, Frankenthaler RA, Gomolin HI, Kadin ME, Lauretano AM. Clinical and pathologic characterization of mucosa-associated lymphoid tissue lymphoma of the head and neck. Ann Otol Rhinol Laryngol. 1998;107:801-806   DOI   PUBMED
12 Song BK, Kim SY, Lee KW, Yun T, Na II, Shin H, et al. Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma. Annals of oncology. 2008;19:242-246   DOI   ScienceOn
13 Pariente D, Anaya JM, Combe B, Jorgensen C, Emberger JM, Rossi JF, et al. Non-Hodgkin's lymphoma associated with primary Sjogren's syndrome. Eur J Med. 1992;1:337-342   PUBMED
14 Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, et al. Regression of primary gastric lymphoma of mucosaassociated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet. 1995;345:1591-1594
15 Fierstein JT, Thawley SE. Lymphoma of the head and neck. La-ryngoscope. 1978;88:583-593